Cargando…
Sulfonylurea: Personalized Medicine for Type 2 Diabetes
Autor principal: | Hwang, You-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722399/ https://www.ncbi.nlm.nih.gov/pubmed/26790382 http://dx.doi.org/10.3803/EnM.2015.30.4.467 |
Ejemplares similares
-
Dipeptidyl peptidase‐4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?
por: Yabe, Daisuke, et al.
Publicado: (2014) -
Sulfonylureas in the Treatment of Type 2 Diabetes Mellitus: A Fresh Look and New Insights
por: Alzaid, Aus
Publicado: (2020) -
Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018) -
Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
por: Hanefeld, M
Publicado: (2007) -
Sulfonylureas: Assets in the past, present and future
por: Kalra, Sanjay, et al.
Publicado: (2015)